Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$360M |
| 2 |
Lam Research
LRCX
|
+$310M |
| 3 |
Medtronic
MDT
|
+$281M |
| 4 |
Cigna
CI
|
+$234M |
| 5 |
Qualcomm
QCOM
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
US Bancorp
USB
|
+$575M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$461M |
| 3 |
UnitedHealth
UNH
|
+$445M |
| 4 |
Johnson & Johnson
JNJ
|
+$411M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$407M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.38% |
| 2 | Healthcare | 11.34% |
| 3 | Financials | 10.59% |
| 4 | Industrials | 8.59% |
| 5 | Consumer Discretionary | 7.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Conagra Brands
CAG
$7.1B
| $55.3M | 0.02% |
1,471,895
-455,614
| -24% | -$16.9M |
|
702
Vanguard Consumer Staples ETF
VDC
$7.96B
| $55.3M | 0.02% |
285,462
+15,429
| +6% | +$2.92M |
|
703
Neurocrine Biosciences
NBIX
$16.3B
| $55.2M | 0.02% |
545,824
-57,776
| -10% | -$6.01M |
|
704
Kadant
KAI
$3.95B
| $55.2M | 0.02% |
264,981
-33,431
| -11% | -$6.79M |
|
705
Paylocity
PCTY
$8.3B
| $55.2M | 0.02% |
277,711
-72,299
| -21% | -$14.2M |
|
706
Synchrony
SYF
$25.7B
| $55.1M | 0.02% |
1,894,499
+1,454,927
| +331% | +$48.9M |
|
707
Occidental Petroleum
OXY
$56B
| $55M | 0.02% |
879,904
+16,125
| +2% | +$1M |
|
708
Celsius Holdings
CELH
$6.12B
| $54.7M | 0.02% |
1,765,551
+233,046
| +15% | +$7.35M |
|
709
Eagle Materials
EXP
$6.46B
| $54.7M | 0.02% |
372,586
-15,778
| -4% | -$2.24M |
|
710
Hubbell
HUBB
$27B
| $54.7M | 0.02% |
224,640
+57,566
| +34% | +$13.8M |
|
711
State Street SPDR S&P Global Natural Resources ETF
GNR
$4.85B
| $54.6M | 0.02% |
956,280
+746
| +0.1% | +$43.5K |
|
712
Kinsale Capital Group
KNSL
$8.52B
| $54.6M | 0.02% |
181,967
+105,509
| +138% | +$30.9M |
|
713
Vanguard International High Dividend Yield ETF
VYMI
$20.8B
| $54.6M | 0.02% |
881,594
-151,726
| -15% | -$9.47M |
|
714
Keysight
KEYS
$58B
| $54.5M | 0.02% |
338,084
-8,550
| -2% | -$1.45M |
|
715
HP
HPQ
$26B
| $54.4M | 0.02% |
1,851,199
-108,753
| -6% | -$3.12M |
|
716
Sprout Social
SPT
$488M
| $54.4M | 0.02% |
893,288
+109,170
| +14% | +$6.68M |
|
717
Schwab US Mid-Cap ETF
SCHM
$14.9B
| $54.2M | 0.02% |
2,396,052
-777,672
| -25% | -$17.9M |
|
718
Vanguard Morningstar Mega Cap ETF
MGC
$10.3B
| $54.1M | 0.02% |
378,285
-74,673
| -16% | -$10.3M |
|
719
Merit Medical Systems
MMSI
$5.24B
| $53.8M | 0.02% |
726,853
-86,224
| -11% | -$6.05M |
|
720
SAP
SAP
$229B
| $53.7M | 0.02% |
423,840
-1,842
| -0.4% | -$216K |
|
721
Invesco S&P 500 Top 50 ETF
XLG
$11B
| $53.7M | 0.02% |
1,727,100
+15,890
| +0.9% | +$466K |
|
722
Fortune Brands Innovations
FBIN
$5.98B
| $53.7M | 0.02% |
913,583
-91,021
| -9% | -$5.57M |
|
723
Royalty Pharma
RPRX
$25.3B
| $53.5M | 0.02% |
1,485,436
+98,288
| +7% | +$3.64M |
|
724
Baker Hughes
BKR
$62.3B
| $53.5M | 0.02% |
1,852,263
+17,827
| +1% | +$539K |
|
725
Tanger
SKT
$4.52B
| $53.4M | 0.02% |
2,744,425
+261,933
| +11% | +$4.86M |
|
Similar funds
Ameriprise's Q1 2023 Portfolio in Review
As of Q1 2023, Ameriprise held 4,099 positions worth $305B, up 4.5% from $292B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Ameriprise's Q1 2023 filing shows 180 new, 1,847 increased, 1,770 reduced and 165 closed positions. Its largest new stake was GE HealthCare: 1,934,385 shares worth $159M. The largest sale was US Bancorp, an estimated $575M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q1 2023 buy was GE HealthCare: 1,934,385 shares worth $159M.
- Ameriprise added most to Walmart Inc in Q1 2023, an estimated $360M increase.
- Ameriprise's biggest Q1 2023 reduction was US Bancorp, cutting an estimated $575M.
- Ameriprise fully exited SVB Financial Group in Q1 2023, selling an estimated $201M.
- Ameriprise's ten largest holdings make up 14% of its $305B portfolio in Q1 2023.
- Ameriprise opened 180 new positions and closed 165 in Q1 2023.
- Ameriprise's portfolio value rose 4.5% quarter-over-quarter to $305B.
Based on Ameriprise's 13F filing for Q1 2023, filed 15 May 2023.